Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of Concordance Between Next-Generation Sequencing Assessment of Microsatellite Instability and Immunohistochemistry-Mismatch Repair From Solid Tumors.
Ali-Fehmi R, Krause HB, Morris RT, Wallbillich JJ, Corey L, Bandyopadhyay S, Kheil M, Elbashir L, Zaiem F, Quddus MR, Abada E, Herzog T, Karnezis AN, Antonarakis ES, Kasi PM, Wei S, Swensen J, Elliott A, Xiu J, Hechtman J, Spetzler D, Abraham J, Radovich M, Sledge G, Oberley MJ, Bryant D. Ali-Fehmi R, et al. Among authors: radovich m. JCO Precis Oncol. 2024 Oct;8:e2300648. doi: 10.1200/PO.23.00648. Epub 2024 Nov 20. JCO Precis Oncol. 2024. PMID: 39565978 Free PMC article.
Evidence for Unified Assessment Criteria of HER2 IHC in Colorectal Carcinoma.
Evans MG, Krause HB, Xiu J, Elliott A, Lou E, Ghani H, Yantiss RK, Garcia-Buitrago M, Matsubara Y, Nakamura Y, Shia J, Yaeger R, Radovich M, Bryant DA, Oberley MJ, Hechtman JF. Evans MG, et al. Among authors: radovich m. Mod Pathol. 2024 Nov 8:100654. doi: 10.1016/j.modpat.2024.100654. Online ahead of print. Mod Pathol. 2024. PMID: 39522645
Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapy.
Clements AN, Casillas AL, Flores CE, Liou H, Toth RK, Chauhan SS, Sutterby K, Deshmukh SK, Wu S, Xiu J, Farrell A, Radovich M, Nabhan C, Heath EI, McKay RR, Subah N, Centuori S, Wheeler TJ, Cress AE, Rogers GC, Wilson JE, Recio-Boiles A, Warfel NA. Clements AN, et al. Among authors: radovich m. bioRxiv [Preprint]. 2024 Oct 24:2024.10.21.618756. doi: 10.1101/2024.10.21.618756. bioRxiv. 2024. PMID: 39484473 Free PMC article. Preprint.
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed Therapy.
Heath E, Dyson G, Ribeiro JR, Xiu J, Poorman K, Mamdani H, Al-Hallak MN, Shields AF, Elayoubi JA, Winer IS, Cackowski FC, Puckrein GA, Lopes GL, Jones N, Hauke RJ, Kareff SA, Radovich M, Sledge GW, Spetzler DB, Vidal GA, Marshall JL. Heath E, et al. Among authors: radovich m. Cancer Res Commun. 2024 Oct 1;4(10):2598-2609. doi: 10.1158/2767-9764.CRC-24-0321. Cancer Res Commun. 2024. PMID: 39172022 Free PMC article.
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Miller CD, Lozada JR, Zorko NA, Elliott A, Makovec A, Radovich M, Heath EI, Agarwal N, Mckay RR, Garje R, Bastos BR, Hoon DSB, Orme JJ, Sartor O, VanderWalde A, Nabhan C, Sledge G, Shenderov E, Dehm SM, Lou E, Miller JS, Hwang JH, Antonarakis ES. Miller CD, et al. Among authors: radovich m. Cancer Res Commun. 2024 May 30;4(5):1369-1379. doi: 10.1158/2767-9764.CRC-23-0546. Cancer Res Commun. 2024. PMID: 38709075 Free PMC article.
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Zorko NA, Makovec A, Elliott A, Kellen S, Lozada JR, Arafa AT, Felices M, Shackelford M, Barata P, Zakharia Y, Narayan V, Stein MN, Zarrabi KK, Patniak A, Bilen MA, Radovich M, Sledge G, El-Deiry WS, Heath EI, Hoon DSB, Nabhan C, Miller JS, Hwang JH, Antonarakis ES. Zorko NA, et al. Among authors: radovich m. Prostate Cancer Prostatic Dis. 2024 Feb 28:10.1038/s41391-024-00797-0. doi: 10.1038/s41391-024-00797-0. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38418892
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
Ardeshir-Larijani F, Schneider BP, Althouse SK, Radovich M, Masood A, Perna F, Salman H, Loehrer PJ. Ardeshir-Larijani F, et al. Among authors: radovich m. JCO Precis Oncol. 2023 Feb;7:e2200465. doi: 10.1200/PO.22.00465. JCO Precis Oncol. 2023. PMID: 36787505 Free PMC article.
A phase II study of buparlisib in relapsed or refractory thymomas.
Abu Zaid MI, Radovich M, Althouse S, Liu H, Spittler AJ, Solzak J, Badve S, Loehrer PJ Sr. Abu Zaid MI, et al. Among authors: radovich m. Front Oncol. 2022 Oct 18;12:891383. doi: 10.3389/fonc.2022.891383. eCollection 2022. Front Oncol. 2022. PMID: 36330484 Free PMC article.
Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlas.
Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, Govekar HR, Kam AE, Reiser J, Turaga K, Radovich M, Zang Y, Qiu Y, Liu Y, Fishel ML, Turk A, Gupta V, Al-Sabti R, Subramanian J, Kuzel TM, Sadanandam A, Waldron L, Hussain A, Saleem M, El-Rayes B, Salahudeen AA, Masood A. Khaliq AM, et al. Among authors: radovich m. Genome Biol. 2022 Jul 13;23(1):156. doi: 10.1186/s13059-022-02724-9. Genome Biol. 2022. PMID: 35831907 Free PMC article. No abstract available.
87 results